Interleukin-8: A Review

References

• Schiffman E, Corcoran B, Wahl S. N-formylmethionyl peptides as chemoattractants for leucocytes. Proc Natl Acad Sci USA 1975; 72: 1059–1062
   PubMed Web of Science ®Google Scholar
• Fernandez H, Henson P, Otani A, et al. Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under simulated in vivo conditions. J Immunol 1978; 120: 109–115
   PubMed Web of Science ®Google Scholar
• Schaw J, Pinckard R, Ferrigni K, et al. Activation of human neu-trophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor). J Immunol 1981; 127: 1250–1255
   PubMed Web of Science ®Google Scholar
• Ford Hutchison A, Bray M, Doig M, et al. Leukotriene B, a potent chemokinetic and aggregating substance released from poly-morphonuclear leukocytes. Nature 1980; 286: 264–265
   PubMed Web of Science ®Google Scholar
• Hunninghake GW., Gadek JE., Fales HM., et al. Human alveolar macrophage-derived chemotactic factor for neutrophils: Stimuli and partial characterization. J Clin Invest 1980; 66: 473–483
   PubMed Web of Science ®Google Scholar
• Merril W, Naegel G, Matthay R, et al. Alveolar macrophage-derived chemotactic factor: Kinetics of in vitro production and partial characterization. J Clin Invest 1980; 65: 268–276
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Matsushima K, Oppenheim J, et al. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leucocytes: Partial characterization and separation from interleukin-1 (IL I). J Immunol 1987; 139: 788–793
   PubMed Web of Science ®Google Scholar
• Schroder J, Mrowietz U, Morita E, et al. Purification and partial biological characterization of a human monocyte-derived, neutrophil activating peptide that lacks interleukin 1 activity. J Immunol 1987; 139
   PubMed Web of Science ®Google Scholar
• Walz A, Peveri P, Aschauer H, et al. Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem Biophys Res Commun 1987; 149: 755–761
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Matsushima K, Tanaka S, et al. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 1987; 84: 9233–9237
   PubMed Web of Science ®Google Scholar
• Van Damme J, Van Beumen J, Opdenakker G, et al. A novel, NH2-terminal sequence characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity. J Exp Med 1988; 167: 1364–1376
   PubMed Web of Science ®Google Scholar
• Gregory H, Young J, Schroder J, et al. Structure determination of a human lymphocyte derived neutrophil activating peptide (LYNAP). Biochem Biophys Res Commun 1988; 151: 883–890
   PubMed Web of Science ®Google Scholar
• Schmid J, Weissmann C. Induction of mRNA for a serine protease and a b-thromboglobulin-like protein in mitogen-stimulated human leukocytes. J Immunol 1987; 139: 250–256
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Robinson E, Appella E, et al. Three forms of monocyte-derived neutrophil chemotactic factor (MDNCF) distinguished by different lengths of the amino-terminal sequence. Mol Immunol 1989; 26: 87–93
   PubMed Web of Science ®Google Scholar
• Van Damme J, Van Beumen J, Conings R, et al. Purification of granulocyte chemotactic peptide/interleukin-8 reveals N-terminal sequence heterogeneity similar to that of b-thromboglobulin. Eur J Biochem 1989; 181: 337–344
   PubMedGoogle Scholar
• Golds E, Mason P, Nyirkos P. Inflammatory cytokines induce synthesis and secretion of gro protein and a neutrophil chemotactic factor but not b2-microglobulin in human synovial cells and fibroblasts. Biochem J 1989; 259: 585–588
   PubMed Web of Science ®Google Scholar
• Gimbrone MJ., Obin M, Brock A, et al. Endothelial interleukin-8: A novel inhibitor of leukocyte-endothelial interactions. Science 1989; 246: 1601–1603
   PubMed Web of Science ®Google Scholar
• Schröder J-M, Sticherling M, Henneicke H, et al. IL-lb or tumor necrosis factor-a stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts. J Immunol 1990; 144: 2223–2232
   PubMed Web of Science ®Google Scholar
• Hébert C, Luscinskas F, Kiely J-M, et al. Endothelial and leukocyte forms of IL-8: Conversion by thrombin and interaction with neutrophils. J Immunol 1990; 145: 3033–3040
   PubMed Web of Science ®Google Scholar
• Nourshargh S, Perkins J, Showell H, et al. A comparative study of the neutrophil stimulatory activity in vitro and pro-inflammatory properties in vivo of 72 amino acid and 77 amino acid IL-8. J Immunol 1992; 148: 106–111
   PubMed Web of Science ®Google Scholar
• Sager R. GRO as a cytokine. Molecular and Cellular Biology of Cytokines, JJ. Oppenheim. Wiley-Liss, New York 1990; 327–332
   Google Scholar
• Oppenheim J, Zachariae C, Mukaida N, et al. Properties of the novel proinflammatory supergene “intercrine” cytokine family. Annu Rev Immunol 1991; 9: 617–648
   PubMed Web of Science ®Google Scholar
• Walz A, Burgener R, Carr B, et al. Structure and characterization of a new member of the interleukin-8-like neutrophil activating peptides: ENA-78. FASEB J 1992; 6: 1780
   Google Scholar
• Wolpe S, Cerami A. Macrophage inflammatory proteins 1 and 2: Members of a novel superfamily of cytokines. FASEB J 1989; 3: 2565–2573
   PubMed Web of Science ®Google Scholar
• Matsushima K, Baldwin E, Mukaida N. Interleukin-8 and MCAF: Novel leukocyte recruitment and activating cytokines. Interleukins: Molecular Biology and Immunology, Vol 51, T Kishimoto. Chem Immunol, Basel 1992; 236–265
   Google Scholar
• Clore G, Appella E, Yamada M, et al. Determination of the secondary structure of interleukin-8 by nuclear magnetic resonance spectroscopy. J Biol Chem 1989; 264: 18907–18911
   PubMedGoogle Scholar
• Clore G, Appella E, Yamada M, et al. Three dimensional structure of interleukin 8 in solution. Biochemistry 1990; 29: 1689–1696
   PubMed Web of Science ®Google Scholar
• Clore G, Gronenborn A. Comparison of the solution nuclear magnetic resonance and crystal structures of interleukin-8: Possible implications for the mechanism of receptor binding. J Mol Biol 1991; 217: 611–620
   PubMed Web of Science ®Google Scholar
• Baldwin E, Weber I, St. Charles R, et al. Crystal structure of interleukin-8: Symbiosis of NMR and crystallography. Proc Natl Acad Sci USA 1991; 88: 502–506
   PubMed Web of Science ®Google Scholar
• Hébert C, Vitangcol R, Baker J. Scanning Mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding. J Biol Chem 1991; 266: 18989–18994
   PubMed Web of Science ®Google Scholar
• Clark-Lewis I, Schumacher C, Baggiolini M, et al. Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities. J Biol Chem 1991; 266: 23128–23134
   PubMed Web of Science ®Google Scholar
• Modi W, Dean M, Seuanez H, et al. Monocyte-derived neutrophil chemotactic factor (MDNCF/IL-8) resides in a gene cluster along with several other members of the platelet factor 4 gene superfamily. Hum Genet 1990; 84: 185–187
   PubMed Web of Science ®Google Scholar
• Griffin C, Emanuel B, Larocco P, et al. Human platelet factor 4 gene is mapped to 4q12-q21. Cytogenet Cell Genet 1987; 45: 67–69
   PubMedGoogle Scholar
• Richmond A, Balentien E, Thomas H, et al. Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to b-thromboglobulin. EMBO J 1988; 7: 2025–2033
   PubMed Web of Science ®Google Scholar
• Luster A, Unkeless J, Chaganti R, et al. Interferon inducible gene maps to a chromosomal band associated with a (4:11) trans-location in acute leukemia cells. Proc Natl Acad Sci USA 1987; 84: 2868–2871
   PubMed Web of Science ®Google Scholar
• Mukaida N, Shiroo M, Matsushima K. Genomic structure of the human monocyte-derived neutrophil chemotactic factor (MDNCF) interleukin-8. J Immunol 1989; 143: 1366–1371
   PubMed Web of Science ®Google Scholar
• Stoekle M. Post-transcriptional regulation of Groa, b, g, and IL-8 mRNAs by IL-1b. Nucleic Acids Res 1991; 19: 917–920
   PubMedGoogle Scholar
• Standiford T, Stricter R, Chensue S, et al. 1L-4 inhibits the expression of IL-8 from stimulated monocytes. J Immunol 1990; 145: 1435–1439
   PubMed Web of Science ®Google Scholar
• Thomsen M, Larsen C, Thestrup-Pederson K. IL 8 is a potent stimulator of neutrophil aggregation and chemotaxis in canine and human neutrophils. Second Int. Symp. on Chemotactic Cytokines, J Westwick. Humana, 1990
   Google Scholar
• Larsen C, Kristensen M, Paludan K, . Endogenous and synthetic inhibitors of the production of chemotactic cytokines. Second Int. Symp. on Chemotactic Cytokines, J Westwick, et al. Plenum Press, New York 1990; 168
   Google Scholar
• Samanta A, Oppenheim J, Matsushima J. Identification and characterization of a specific receptor for monocyte-derived neutrophil chemotactic factor (MDNCF) on human neutrophils. J Exp Med 1989; 169: 1185–1189
   PubMed Web of Science ®Google Scholar
• Moser B, Schumacher C, von Tscharner V, et al. Neutrophil-activating peptide 2 and gro/melanoma growth stimulatory activity interact with neutrophil-activating peptide 1/interleukin-8 receptors on human neutrophils. J Biol Chem 1991; 266: 10666–10671
   PubMed Web of Science ®Google Scholar
• Holmes W, Lee J, Kuang W-J, et al. Structure and functional expression of a human interleukin-8 receptor. Science 1991; 253: 1278–1280
   PubMed Web of Science ®Google Scholar
• Murphy P, Tiffany H. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 1991; 253: 1280–1283
   PubMed Web of Science ®Google Scholar
• Besemer J, Hujber A, Kuhn B. Specific binding, internaliza-tion, and degradation of human neutrophil activating factor by human polymorphonuclear leukocytes. J Biol Chem 1989; 264: 17409–17415
   PubMed Web of Science ®Google Scholar
• Grob P, David E, Warren T, et al. Characterization of a receptor for human monocyte-derived neutrophil chemotactic factor/inter-leukin-8. J Biol Chem 1990; 265: 8311–8316
   PubMed Web of Science ®Google Scholar
• Lee J, Horuk R, Rice G, et al. Characterization of two high affinity human interleukin-8 receptors. J Biol Chem 1992; 267: 16283–16287
   PubMed Web of Science ®Google Scholar
• Samanta A, Oppenheim J, Matsushima J. Interleukin-8 (MDNCF) dynamically regulates its own receptor expression on human neutrophils. J Biol Chem 1989; 265: 183–189
   Web of Science ®Google Scholar
• Vachula M, Bornstein I, Van Epps D. Role of granulocyte-macrophage colony stimulating factor (GM-CSF) in regulating the interleukin-8 (IL-8) receptor. FASEB J 1991; 5: A1632
   Web of Science ®Google Scholar
• Peveri P, Walz A, Dewald B, et al. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med 1988; 167: 1547–1559
   PubMed Web of Science ®Google Scholar
• Thelen M, Peveri P, Kernen P, et al. Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist. FASEB J 1988; 2: 2702–2706
   PubMed Web of Science ®Google Scholar
• Westlin W, Kiely J-M, Gimbrone MJ. Interleukin-8 induces changes in human neutrophil actin conformation and distribution: Relationship to inhibition of adhesion to cytokine-activated endothelium. J Leukocyte Biol 1992; 51,52: 43–51
   Web of Science ®Google Scholar
• Pacaud J-P, Schifferli J, Baggiolini M. NAP-1/IL-8 induces up-regulation of CRI receptors in human neutrophil leukocytes. Biochem Biophys Res Commun 1990; 166: 187–192
   PubMed Web of Science ®Google Scholar
• Detmers P, Powell D, Walz A, et al. Differential effects of neutrophil activating peptide 1/IL-8 and its homologues on leukocyte adhesion and phagocytosis. J Immunol 1991; 147: 4211–4217
   PubMed Web of Science ®Google Scholar
• Luscinskas F, Kiely J-M, Ding H, et al. The in vitro inhibitory effect of IL-8 and other chemoattractants on neutrophil-endothelial adhesive interactions. J Immunol 1992; 149: 2163–2171
   PubMed Web of Science ®Google Scholar
• Daniels R, Finnen M, Hill M, et al. Recombinant human monocyte IL-8 primes NADPH-oxidase and phospholipase A2 activation in human neutrophils. Immunology 1992; 75: 157–163
   PubMed Web of Science ®Google Scholar
• Sehmi R, Wardlaw A, Cromwell O, et al. Effect of Th2 related cytokines and interleukin-8 (IL-8) on eosinophil locomotion. FASEB J 1992; 6: A1435
   Web of Science ®Google Scholar
• Larsen CG., Anderson AO., Appella E, et al. Neutrophil activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 1989; 243: 1464–1466
   PubMed Web of Science ®Google Scholar
• Leonard E, Skeel A, Yoshimura T, et al. Leukocyte specificity and binding of human neutrophil attractant/activating protein 1. J Immunol 1990; 144: 1323–1330
   PubMed Web of Science ®Google Scholar
• Brown K, LeRoy F, Noble G, . IL 8 acts on monocytes to increase their attachment to cultured endothelium and enhance their expression of surface adhesion molecules. Second Int. Symp. on Chemotactic Cytokines, J Westwick, et al. Humana. 1990
   Google Scholar
• Kuna P, Reddigari S, Kornfeld D, et al. IL-8 inhibits histamine release from human basophils induced by histamine releasing factors, connective tissue activating peptide III, and IL-3. J Immunol 1991; 147: 1920–1924
   PubMed Web of Science ®Google Scholar
• Alam R, Forsythe P, Lett-Brown M, et al. IL-8 and RANTES inhibit monocyte chemotactic and activating factor (MCAF)-induced histamme release from purified basophils. FASEB J 1992; 6: A2005
   Web of Science ®Google Scholar
• Darbonne W, Rice G, Mohler M, et al. Red blood cells are a sink for interleukin-8, a leukocyte chemotaxin. J Clin Invest 1991; 88: 1362–1369
   PubMed Web of Science ®Google Scholar
• Colditz I, Zwahlen R, Dewald B, et al. In vivo inflammatory activity of neutrophil activating factor, a novel chemotactic pep-tide derived from human monocytes. Am J Pathol 1989; 134: 755–760
   PubMed Web of Science ®Google Scholar
• Rampart M, Van Damme J, Zonnekeyn L, et al. Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin. Am J Pathol 1989; 135: 21–25
   PubMed Web of Science ®Google Scholar
• Colditz I, Zwahlen R, Dewald B, et al. Neutrophil accumulation and plasma leakage induced in vivo by neutrophil-activating peptide-1. J Leukocyte Biol 1990; 48: 129–137
   PubMed Web of Science ®Google Scholar
• Swensson O, Schubert C, Christopher E, et al. Inflammatory properties of neutrophil-activating protein-1/interleukin-8 (NAP-1/IL-8) in human skin: A light and electron microscopic study. J Invest Dermatol 1991; 96: 682–689
   PubMed Web of Science ®Google Scholar
• Leonard E, Yoshimura T, Tanaka S, et al. Neutrophil recruitment by intradermally injected neutrophil at tractant/activation protein-1. Invest Dermatol 1991; 96: 690–694
   PubMed Web of Science ®Google Scholar
• Hechtman D, Cybalsky M, Fuchs H, et al. Intravascular IL-8: Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J Immunol 1991; 147: 883–892
   PubMed Web of Science ®Google Scholar
• Van Zee K, Fischer E, Hawes A, et al. Effects of intravenous IL-8 administration in nonhuman primates. J Immunol 1992; 148: 1746–1752
   PubMed Web of Science ®Google Scholar
• Sticherling M, Bornscheuer E, Schroder J-M, et al. Localization of neutrophil-activating peptide-1/interleukin-8-immuno-reactivity in normal and psoriatic skin. J Invest Dermatol 1991; 96: 26–30
   PubMed Web of Science ®Google Scholar
• Nickoloff B, Karabin G, Barker J, et al. Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-α in psoriasis. Am J Pathol 1991; 138: 129–140
   PubMed Web of Science ®Google Scholar
• Brennan F, Zachariae C, Chantry D, et al. Detection of interleu-kin 8 (IL 8) biological activity in synovial fluid from patients with rheumatoid arthritis and production of IL 8 mRNA by isolated synovial cells. Eur J Immunol 1990; 20: 2141–2144
   PubMed Web of Science ®Google Scholar
• Peichl P, Ceska M, Effenberger F, et al. Presence of NAP-1/IL-8 in synovial fluids indicates a possible pathogenic role in rheumatoid arthritis. Scand J Immunol 1991; 34: 333–339
   PubMed Web of Science ®Google Scholar
• Koch A, Kunkel S, Burrows J, et al. Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. I Immunol 1991; 147: 2187–2195
   PubMed Web of Science ®Google Scholar
• Terkeltaub R, Zachariae C, Santoro D, et al. Monocyte-derived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystal-induced inflammation. Arthritis Rheum 1991; 34: 894–903
   PubMed Web of Science ®Google Scholar
• Broaddus V, Hébert C, Vitangcol R, et al. Interleukin-8 is a major neutrophil chemotactic factor in pleural liquid of patients with empyema. Am Rev Respir Dis 1992; 146: 825–830
   PubMed Web of Science ®Google Scholar
• Carre P, Mortenson R, King T, et al. Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. J Clin Invest 1991; 88: 1802–1810
   PubMed Web of Science ®Google Scholar
• Miller EJ., Cohen AB., Nagao S, et al. Elevated levels of NAP1/Interleukin-8 are present in the airspaces of patients with Adult Respiratory Distress Syndrome and are associated with increased mortality. Am Rev Resp Dis 1992; 146: 427–432
   PubMed Web of Science ®Google Scholar
• McElvaney N, Nakamura H, Birrer P, et al. Modulation of airway inflammation in cystic fibrosis: In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aero-solization of recombinant secretory leukoprotease inhibitor. J Clin Invest 1992; 90: 1296–1301
   PubMed Web of Science ®Google Scholar
• Huber A, Kunkel S, Todd RI., et al. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 1991; 254: 99–102
   PubMed Web of Science ®Google Scholar
• Yoshida M, Matsuzaki H, Sakata K, et al. Neutrophil chemotactic factors produced by a cell line from thyroid carcinoma. Cancer Res 1992; 52: 464–469
   PubMed Web of Science ®Google Scholar
• Abruzzo L, Thornton A, Liebert M, et al. Cytokine-induced gene expression of interleukin-8 in human transitional cell carcinomas and renal cell carcinomas. Am J Pathol 1992; 140: 365–373
   PubMed Web of Science ®Google Scholar
• Eto H, Yonemoto K, Sekine A, et al. Production of interleukin-8 by human trichilemmoma and squamous cell carcinoma cell lines. Clin Res 1991; 39: 517A
   PubMedGoogle Scholar
• Förster E, Kirnbauer R, Urbanski A, et al. Human melanoma cells produce interleukin 8 which functions as an autocrine growth factor. Clin Res 1991; 39: 517A
   PubMedGoogle Scholar
• Kasahara T, Mukaida N, Yamashita K, et al. IL-1 and TNF induction of IL-8 and monocyte chemotactic and activating factor (MCAF) mRNA expression in a human astrocytoma cell line. Immunology 1991; 74: 60–67
   PubMed Web of Science ®Google Scholar
• Thornton A, Ham J, Kunkel S. Kupffer cell-derived cytokines induce the synthesis of a leukocyte chemotactic peptide, interleukin-8, in human hepatoma and primary hepatocyte cultures. Hepatology 1992; 15: 1112–1122
   PubMedGoogle Scholar
• Hansen E, Vejlsgaard G, Lisby S, et al. Epidermal interleukin la functional activity and interleukin 8 immunoreactivity are increased in patients with cutaneous T-cell lymphoma. J Invest Dermatol 1992; 97: 818–823
   Web of Science ®Google Scholar
• Richmond A. The pathogenic role of growth factors in melanoma. Semin Dermatol 1991; 10: 246–255
   PubMedGoogle Scholar
• Opdenakker G, Van Damme J. Chemotactic factors, passive invasion and metastasis of cancer cells. Immunol Today 1992; 13: 463–464
   PubMedGoogle Scholar
• Koch A, Polverini P, Kunkel S, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258: 1798–1801
   PubMed Web of Science ®Google Scholar